Comparative study on retracted publications explores whether COVID-19-related research is subject to a higher degree of scrutiny

In a recent research letter published in JAMA Network Open, a team of researchers compared the author characteristics and causes for manuscript retractions of coronavirus disease 2019 (COVID-19) and non-COVID-19 related research.

Study: Characteristics of Retracted Research Articles About COVID-19 vs Other Topics. Image Credit: Cozine/Shutterstock
Study: Characteristics of Retracted Research Articles About COVID-19 vs Other Topics. Image Credit: Cozine/Shutterstock

Background

Published papers from peer-reviewed journals are generally withdrawn or retracted because of major errors, fraudulent results, or other academic misconduct. Statistics suggest that the frequency of retractions has increased in recent times.

Since the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) pandemic, COVID-19 research has also seen many retractions, possibly due to increased investigation into the subject. However, it poses questions about whether retractions of COVID-19-related research and other medical studies are similar in the reasons for withdrawal or the author’s characteristics.

About the study

In the present cross-sectional study, the researchers used the Retraction Watch Database (RWDB) to identify all retracted publications and preprints on COVID-19 and non-COVID-19-related research since February 1, 2020.

Information about the withdrawn studies, such as type of publication, author affiliations, the impact factor of the journal in 2020, and the date of retraction, was recorded. The studies were grouped according to the prominent causes of retraction. Author profiles and affiliations were verified using Scopus and Google Scholar. The years since the first publication and the H-indices of the first and last authors were compared for the two categories. The H-index is a metric indicating the productivity and citation impact of the publications from an author.

Statistical analyses to compare the various characteristics of the two retraction categories in this study included the Mann-Whitney U and Fisher Exact tests.

Results

The results indicated significant differences in the reasons, timelines, and study designs between retracted COVID-19 studies and withdrawn articles from other medical fields. The authors found 138 retracted studies on COVID-19 and 380 article retractions on non-COVID-19-related research. Of the 138 COVID-19 studies, 101 were published papers, and 37 were preprints. In comparison, all 380 non-COVID-19 retractions were published studies.

The study revealed that COVID-19-related articles were more likely to be withdrawn in the first six months from publication than non-COVID-19-related medical articles (81.9% vs 59.7%). The study design and retraction reasons also varied significantly between the two categories. COVID-19 studies were withdrawn mostly for non-misconduct reasons, with a large proportion being modeling studies. Furthermore, compared to COVID-19 studies, more non-COVID-19-related article retractions were initiated by journals, editors, or publishers.

The first and last authors of the COVID-19-related retracted articles had a longer publication history and a higher median H-index than those of withdrawn non-COVID-19 publications.

The authors noted that while most of the retracted COVID-19 studies were not associated with academic fraud or misconduct, many of the retraction notices did not provide detailed explanations for the cause of withdrawal. Moreover, the retraction notices were also not uniform across publishers and journals, making it difficult to decipher the reasons for the withdrawal.

Conclusions

To summarize, this cross-sectional study compared retracted COVID-19 and non-COVID-19 related studies to understand similarities or differences in reasons for retraction and author characteristics. The findings suggested that many COVID-19-related studies were withdrawn for reasons unrelated to academic misconduct, but not all retractions were accompanied by detailed explanations on the RWDB.

Furthermore, a large portion of the examined COVID-19-related article withdrawals occurred in the six months following publication, indicating that research on the SARS-CoV-2 pandemic was under increased scrutiny.

Notably, most of the non-COVID-19 related medical studies were retracted by journals, publishers, or editors, and not the authors.

Journal reference:
Dr. Chinta Sidharthan

Written by

Dr. Chinta Sidharthan

Chinta Sidharthan is a writer based in Bangalore, India. Her academic background is in evolutionary biology and genetics, and she has extensive experience in scientific research, teaching, science writing, and herpetology. Chinta holds a Ph.D. in evolutionary biology from the Indian Institute of Science and is passionate about science education, writing, animals, wildlife, and conservation. For her doctoral research, she explored the origins and diversification of blindsnakes in India, as a part of which she did extensive fieldwork in the jungles of southern India. She has received the Canadian Governor General’s bronze medal and Bangalore University gold medal for academic excellence and published her research in high-impact journals.

Citations

Please use one of the following formats to cite this article in your essay, paper or report:

  • APA

    Sidharthan, Chinta. (2022, October 06). Comparative study on retracted publications explores whether COVID-19-related research is subject to a higher degree of scrutiny. News-Medical. Retrieved on November 02, 2024 from https://www.news-medical.net/news/20221006/Comparative-study-on-retracted-publications-explores-whether-COVID-19-related-research-is-subject-to-a-higher-degree-of-scrutiny.aspx.

  • MLA

    Sidharthan, Chinta. "Comparative study on retracted publications explores whether COVID-19-related research is subject to a higher degree of scrutiny". News-Medical. 02 November 2024. <https://www.news-medical.net/news/20221006/Comparative-study-on-retracted-publications-explores-whether-COVID-19-related-research-is-subject-to-a-higher-degree-of-scrutiny.aspx>.

  • Chicago

    Sidharthan, Chinta. "Comparative study on retracted publications explores whether COVID-19-related research is subject to a higher degree of scrutiny". News-Medical. https://www.news-medical.net/news/20221006/Comparative-study-on-retracted-publications-explores-whether-COVID-19-related-research-is-subject-to-a-higher-degree-of-scrutiny.aspx. (accessed November 02, 2024).

  • Harvard

    Sidharthan, Chinta. 2022. Comparative study on retracted publications explores whether COVID-19-related research is subject to a higher degree of scrutiny. News-Medical, viewed 02 November 2024, https://www.news-medical.net/news/20221006/Comparative-study-on-retracted-publications-explores-whether-COVID-19-related-research-is-subject-to-a-higher-degree-of-scrutiny.aspx.

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
Post

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

You might also like...
Study finds nirmatrelvir-ritonavir reduces severe COVID-19 and long COVID risks in high-risk patients